NEW DELHI: Experts in the pharma industry have raised their concerns over the government’s move to notify a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers. Experts said a chain-wide MIP on Pen-G, 6-APA and amoxicillin would raise costs across essential medicines, disrupt government tenders…
Mumbai: Novo Nordisk’s move to launch its second GLP-1 injectable drug brand, Ozempic, in India at a lower price than its own Wegovy and rival Eli Lilly’s Mounjaro positions the company for a sharper push into the country’s rapidly expanding weight-loss market. While Ozempic (semaglutide) is prescribed for Type-2 diabetes, the drug that mimics the…
India‘s drug regulator has sought comments from pharma industry stakeholders on rules that require the first applicant to conduct clinical trials and bioequivalence studies, while the subsequent filers could skip the trials and have an easier path to obtaining approvals for a product launch. Experts, however, believe that instead of making drugs cheaper, the move…
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link